Trial	Phase	Sponsor	Dist.
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers	N/A	LifeNet Health	<1 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	N/A	Piomic Medical	<1 mi
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers	N/A	Tides Medical	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	<1 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	<1 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes	N/A	Endogenex, Inc.	<1 mi
Smart Boot Use to Measure Offloading Adherence	Phase 2	University of Southern California	<1 mi
Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers	N/A	University of Southern California	<1 mi
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy	Phase 2	Boehringer Ingelheim	<1 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes	Phase 3	Sanofi	<1 mi
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight	Phase 3	Eli Lilly and Company	<1 mi
Fenofibrate for Prevention of DR Worsening	Phase 3	Jaeb Center for Health Research	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
TrialNet Pathway to Prevention of T1D	—	University of South Florida	<1 mi
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting	—	Bayer	<1 mi
A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's	N/A	Compedica Inc	<1 mi
DFC 004 Biomarkers for Active Diabetic Foot Ulcers	—	University of Michigan	<1 mi
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)	—	M.D. Anderson Cancer Center	<1 mi
Continuous Glucose Monitoring in Prediabetes With Health Education Videos	N/A	David S Black, PhD	<1 mi
Type 2 Diabetes and Blood Brain Barrier Improvement	Early 1	University of California, Los Angeles	<1 mi
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.	N/A	Molnlycke Health Care AB	<1 mi
New T-UP: Engaging Vulnerable Students in Diabetes Prevention	N/A	University of California, Los Angeles	<1 mi
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)	N/A	Children's Hospital Los Angeles	<1 mi
Transformative Research in Diabetic Nephropathy	—	University of Pennsylvania	<1 mi
DETERMINE: Detemir vs NPH	Phase 2	University of California, Los Angeles	<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	<1 mi
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers	N/A	Integra LifeSciences Corporation	<1 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	<1 mi
Device Use Reimagined Through Education And Mentorship	N/A	University of California, San Francisco	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms	—	Milton S. Hershey Medical Center	<1 mi
CGM Academy for Youth With Type 1 Diabetes	N/A	Children's Hospital Los Angeles	<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)	—	Jaeb Center for Health Research	<1 mi
Adapting Lifestyle Offloading for DFUs	N/A	University of Southern California	<1 mi
Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center	N/A	Cedars-Sinai Medical Center	<1 mi
Designing Team Clinic for Youth With Type 2 Diabetes	—	Children's Hospital Los Angeles	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes	Phase 4	Ohio State University	<1 mi
Implementation of Team Clinic for Type 2 Diabetes (TCT2)	N/A	Children's Hospital Los Angeles	<1 mi
Type 2 Continuous Glucose Monitoring Academy	N/A	Children's Hospital Los Angeles	<1 mi
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus	Phase 1	Eli Lilly and Company	<1 mi
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth	—	George Washington University	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics	—	Milton S. Hershey Medical Center	<1 mi
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children	N/A	University of Southern California	<1 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1D	Phase 1	GentiBio, Inc	<1 mi
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes	Phase 3	Vertex Pharmaceuticals Incorporated	<1 mi
Dietary Intervention to Improve Kidney Transplant Outcomes	N/A	University of California, Davis	<1 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes	N/A	Medtronic Diabetes	<1 mi
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes	N/A	University of California, Davis	<1 mi
Use of CGM in Kidney Transplant Recipients	N/A	University of California, Davis	<1 mi
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD	Phase 2	University of California, Davis	<1 mi
Metabolic Responses to Bariatric Surgery	—	University of California, Davis	<1 mi
Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management	N/A	Legacy Medical Consultants	<1 mi
Type 1 Diabetes Extension Study	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem	N/A	University of California, San Francisco	<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
Precision Dosing of Metformin in Youth With T2D	Early 1	University of California, San Francisco	<1 mi
Commercial or Open Source Closed Loop Impact on Pregnancy Study	—	University of California, San Francisco	<1 mi
A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States	—	Sanofi	<1 mi
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial	Phase 2	Jason Sperry	<1 mi
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)	Phase 2	Sanofi	<1 mi
HLA Demographics Study in Adults With Type 1 Diabetes	—	GentiBio, Inc	<1 mi
Extended Bolus for Meals in a Closed-loop System	Phase 4	University of California, San Francisco	<1 mi
AIDANET Pediatrics	N/A	Mark D. DeBoer, MD, MSc., MCR	<1 mi
Village-Integrated Eye Worker Trial II	N/A	University of California, San Francisco	<1 mi
Inflammation, Diabetes, Ethnicity and Obesity Cohort	—	University of California, San Francisco	<1 mi
Automated Insulin for Management of Intrapartum Glycemia	N/A	University of California, San Francisco	<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes	Phase 3	vTv Therapeutics	<1 mi
OPTDR01 Feasibility for Automated Diabetic Retinopathy Detection	—	Optain Health	<1 mi
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age	N/A	Scripps Whittier Diabetes Institute	<1 mi
Project Dulce for Filipino-Americans With Type 2 Diabetes	N/A	Scripps Whittier Diabetes Institute	<1 mi
Enhancing Digitally Delivered Diabetes Education With Real-Time CGM	N/A	Scripps Whittier Diabetes Institute	<1 mi
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population	N/A	San Diego State University	<1 mi
Efficacy of Using Mobile Health Applications for Health	N/A	San Diego State University	<1 mi
More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus	N/A	University of California, San Diego	<1 mi
CGM for Management of Type 2 Diabetes in Pregnancy	N/A	University of Alabama at Birmingham	<1 mi
Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone	N/A	Capsicure, LLC	<1 mi
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes	Phase 2	Scripps Whittier Diabetes Institute	<1 mi
Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes	N/A	University of California, San Diego	<1 mi
Dosimetry of Tc-99m-Tilmanocept	Phase 1	University of California, San Diego	<1 mi
Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults	N/A	San Diego State University	<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
Implementing Food Referrals for Equity and Sustained Health	Phase 2	University of California, San Diego	<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Phase 3	Eli Lilly and Company	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
Immediate Postpartum Glucose Tolerance Testing	—	MemorialCare Health System	<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	<1 mi
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine	N/A	Southern California Institute for Research and Education	<1 mi
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus	Phase 2	Ascletis Pharma (China) Co., Limited	<1 mi
Safer Aging With Diabetes Monitoring	N/A	Kaiser Permanente	<1 mi
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort	Phase 1	AstraZeneca	6 mi
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)	Phase 1	Merck Sharp & Dohme LLC	6 mi
Different Doses of Naronapride Vs. Placebo in Gastroparesis	Phase 2	Dr. Falk Pharma GmbH	7 mi
MiniMed Fit Payload Wear Study	—	Medtronic Diabetes	7 mi
Latinos Understanding the Need for Adherence in Diabetes Using E-Health	N/A	San Diego State University	7 mi
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)	Phase 1	Merck Sharp & Dohme LLC	7 mi
A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500	Phase 1	Portal Diabetes, Inc.	7 mi
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus	Phase 2	Hanmi Pharmaceutical Company Limited	7 mi
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus	Phase 1	Amgen	7 mi
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus	Phase 2	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	7 mi
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	7 mi
Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes	N/A	Kaiser Permanente	8 mi
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions	Phase 1/2	Thomas Advanced Medical LLC	9 mi
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01	Phase 2	Vantage Biosciences Ltd	9 mi
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes	Phase 1/2	Metsera, a wholly owned subsidiary of Pfizer	10 mi
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes	Phase 3	Kailera	10 mi
Starting Technology in At Risk Type 1 Diabetes Study	N/A	University of California, Los Angeles	10 mi
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT	Phase 4	Matthew J. Budoff	10 mi
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin	Phase 2	Eli Lilly and Company	10 mi
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.	Phase 4	Royal Biologics	10 mi
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes	Phase 2	Hoffmann-La Roche	10 mi
Closed Loop and Education for Hypoglycemia Awareness Restoration	N/A	Milton S. Hershey Medical Center	11 mi
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health	Phase 2	University of California, San Diego	11 mi
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes	Phase 1/2	University of California, San Diego	11 mi
Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7	N/A	Scripps Whittier Diabetes Institute	11 mi
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial	Phase 2	University of California, San Diego	11 mi
Time-Restricted Eating for Type II Diabetes: TRE-T2D	N/A	University of California, San Diego	11 mi
THC Effects on Glucose in Type 2 Diabetes	Phase 1	University of California, San Diego	11 mi
Project Dulce for Arab Americans With Type 2 Diabetes	N/A	Scripps Whittier Diabetes Institute	13 mi
Metabolic and Bio-behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans	N/A	USDA, Western Human Nutrition Research Center	14 mi
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes	Phase 1	Stanford University	16 mi
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation	Phase 2	Qlaris Bio, Inc.	16 mi
CHIME: Comparing Health Interventions for Maternal Equity	N/A	Stanford University	16 mi
Food Insecurity Reduction & Strategy Team	N/A	Stanford University	16 mi
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease	N/A	Duk-Woo Park, MD	16 mi
Denosumab for Type 1 Diabetes	Phase 1/2	City of Hope Medical Center	16 mi
Circulating Biomarkers in the Development of Type 1 Diabetes	—	City of Hope Medical Center	16 mi
Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes	Phase 1/2	City of Hope Medical Center	16 mi
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone	N/A	Capsicure, LLC	17 mi
BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes	N/A	Stanford University	17 mi
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)	N/A	Stanford University	17 mi
Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes	N/A	Stanford University	17 mi
SPYRAL GEMINI Pilot Study	N/A	Medtronic Vascular	17 mi
Post Prandial Individual Responses to Different Foods	N/A	Stanford University	17 mi
Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep	N/A	Stanford University	17 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease	Phase 3	Alessandro Doria	17 mi
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance	N/A	Stanford University	17 mi
High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy	Phase 4	Retina Consultants of Orange County	17 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Eli Lilly and Company	19 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity	Phase 3	Eli Lilly and Company	19 mi
EDX110 Randomized Control Trial for Treatment of DFUs	N/A	ConvaTec Inc.	19 mi
Conscious Pregnancy: Supporting Maternal Cardiometabolic Health With Mindfulness	N/A	University of California, Irvine	19 mi
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	19 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide	Phase 2	Eli Lilly and Company	19 mi
Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial	N/A	University of California, Irvine	20 mi
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease	Phase 2	Regeneron Pharmaceuticals	21 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes	Phase 3	Kailera	21 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes	Phase 3	Kailera	21 mi
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM	N/A	i-SENS, Inc.	21 mi
Dementia and Diabetes Prevention Program	N/A	University of California, Davis	21 mi
The iLet Experience Study	—	Beta Bionics, Inc.	22 mi
HOPE Intervention for Fitness	N/A	University of California, Irvine	22 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease	Phase 2	Novo Nordisk A/S	24 mi
Addressing Diabetes by Elevating Access to Nutrition	N/A	Stanford University	25 mi
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature	N/A	Senseonics, Inc.	28 mi
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC	N/A	Surgenex	34 mi
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers	N/A	Axolotl Biologix	35 mi
Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy	—	Averitas Pharma, Inc.	36 mi
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight	Phase 3	Eli Lilly and Company	48 mi
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)	Phase 4	Cellution Biologics	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.